Skip to main content
See every side of every news story
Published loading...Updated

Tamil Nadu Govt Revokes Manufacturing License for Coldrif Cough Syrup; Firm Permanently Shut Down

  • On Monday, the Enforcement Directorate launched searches at seven Chennai premises linked to Sresan Pharmaceuticals under the Prevention of Money Laundering Act, targeting residences and offices of senior Tamil Nadu Drug Control Department officials and the proprietor's home.
  • Laboratory tests in Chennai confirmed Coldrif cough syrup contained 48.6 per cent Diethylene Glycol, a toxic solvent causing irreversible kidney failure when ingested.
  • Regulatory inspections found Sresan Pharmaceuticals, licensed by the Tamil Nadu Food and Drug Administration in 2011, committed over 300 violations, including use of non-pharmaceutical grade chemicals and poor GMP/GLP practices.
  • The Tamil Nadu government revoked Sresan Pharmaceuticals' licences and ordered its closure on October 13, 2025, while suspending two senior drug inspectors and arresting proprietor G. Ranganathan.
  • The probe is focusing on the money trail and shell firms as the Enforcement Directorate registered a PMLA case while multiple states banned Coldrif and warned parents, sealing five medical stores.
Insights by Ground AI
Podcasts & Opinions

36 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources lean Right
55% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Free Press Journal broke the news in Mumbai, India on Sunday, October 12, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal